Loading…
Loading the latest PSX data…
Loading the latest PSX data…
AGP Limited (AGP), GlaxoSmithKline Pakistan Limited (GLAXO): performance, valuation, growth, risk and danioPSX score, side by side.
Add a stock
Growth of Rs 100 from 2025-11-11
Daily closes from PSX end-of-day files, adjusted for bonus shares, right issues and splits (not for cash dividends). KSE-100: official closes where available, otherwise rebuilt from its constituents.
| Measure | AGPPharmaceuticals | GLAXOPharmaceuticals |
|---|---|---|
| danioPSX score | 50 | 89 |
| Price and size | ||
| Price | Rs 155.45 | Rs 339.59 |
| Today | −0.59% | +0.96% |
| Market cap | Rs 43.5bn | Rs 108.1bn |
| Traded per day | Rs 35m | Rs 49m |
| Valuation and dividends | ||
| P/E | 24.3 | 9.9 |
| Dividend yield | 5.1% | 6.1% |
| EPS (last year) | Rs 8.43 | Rs 31.48 |
| Business | ||
| EPS growth | +13.3% | +53.4% |
| Sales growth | +10.8% | +7.7% |
| Net margin | 11.5% | 15.2% |
| Returns | ||
| 1 month | −3.9% | +8.9% |
| 3 months | −16.6% | −1.6% |
| 1 year | −16.6% | −13.9% |
| vs KSE-100, 1 year | -29.6 pts | -27.0 pts |
| Trend and risk | ||
| 52-week position | 9% | 28% |
| RSI 14 | 49 | 65 |
| RS rank | 18 | 42 |
| Volatility | 40% | 34% |
| Beta | 1.07 | 1.05 |
| danioPSX score | ||
| Value | 12 | 69 |
| Quality | 71 | 81 |
| Dividend | 57 | 64 |
| Momentum | 18 | 40 |
| Safety | 68 | 80 |
| Shariah-compliant | Yes | Yes |
Bold marks the best value in each row where higher (or, for P/E and volatility, lower) is clearly better.
A comparison of published numbers, not a recommendation. Share this page: the address holds the stocks. Find more stocks with the screener